HPV vaccination of immunocompromised hosts

It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to na...

ver descrição completa

Detalhes bibliográficos
Autores: Garland, Suzanne M., Brotherton, J. M. L., Moscicki, Anna-Barbara, Kaufmann, A. M., Stanley, Margaret, Bhatla, N., Sankaranarayanan, Rengaswamy, Sanjosé Llongueras, Silvia de, Palefsky, Joel
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Recursos:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/124030
Acesso em linha:https://hdl.handle.net/2445/124030
Access Level:acceso abierto
Palavra-chave:Vacuna del papil·lomavirus
Papillomavirus vaccines
Descrição
Resumo:It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.

Registos relacionados